Package 55466-130-12

{"route": ["ORAL"], "spl_id": "37b2aadd-c545-9ecf-e063-6394a90a2cb0", "openfda": {"unii": ["6DPV8NK46S", "G83415V073", "JJ768O327N", "H527KAP6L5"], "rxcui": ["541363", "541878", "541892", "577957", "577961"], "spl_set_id": ["c922de13-7ae0-a09c-e053-2995a90a4411"], "manufacturer_name": ["Neolpharma, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (55466-130-12)", "package_ndc": "55466-130-12", "marketing_start_date": "20250205"}], "brand_name": "Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate", "product_id": "55466-130_37b2aadd-c545-9ecf-e063-6394a90a2cb0", "dosage_form": "TABLET", "pharm_class": ["Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Central Nervous System Stimulation [PE]", "Central Nervous System Stimulation [PE]"], "product_ndc": "55466-130", "dea_schedule": "CII", "generic_name": "Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate", "labeler_name": "Neolpharma, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate", "active_ingredients": [{"name": "AMPHETAMINE ASPARTATE", "strength": "2.5 mg/1"}, {"name": "AMPHETAMINE SULFATE", "strength": "2.5 mg/1"}, {"name": "DEXTROAMPHETAMINE SACCHARATE", "strength": "2.5 mg/1"}, {"name": "DEXTROAMPHETAMINE SULFATE", "strength": "2.5 mg/1"}], "application_number": "ANDA210754", "marketing_category": "ANDA", "marketing_start_date": "20250205", "listing_expiration_date": "20261231"}